Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: September 9, 2026
Reporting Period: Single event date (September 9, 2026)
The filing discloses a regulatory milestone regarding the Company's Intelligent Fingerprinting Drug Screening System. The Company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC.
Key Financial Metrics
This Form 8-K is a current report regarding a specific corporate event and does not contain financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.
Material Changes
The material change reported is the submission of a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA). This submission seeks regulatory clearance for the Company's Intelligent Fingerprinting Drug Screening System specifically for the detection of the opiate codeine.
Guidance, Outlook, and Risks
Management Commentary: The Company announced the submission of the 510(k) notification as a significant step in its regulatory pathway for codeine detection.
Risks and Contingencies: The filing notes that the information is qualified in its entirety by the full text of the accompanying press release (Exhibit 99.1). As with all premarket notifications, there is an inherent risk that the FDA may not grant clearance, or may request additional data, though specific risk factors are not detailed in this summary text.
Investor Verification Checklist
- Verify the status of the 510(k) submission for codeine detection via the FDA database or subsequent press releases.
- Review Exhibit 99.1 (Press Release) for detailed technical specifications and expected timelines for FDA review.
- Confirm if the codeine detection capability represents a new revenue stream or an expansion of existing product lines.
- Monitor for any FDA requests for additional information or decisions on the clearance application.